http://atvb.ahajournals.org/cgi/content/short/30/4/781?rss=1
Submitted by
cardiologylinks
4 months, 1 week, 4 days, 16 hours ago
Objective— We previously reported that a systemic liver X receptor (LXR) agonist promoted macrophage reverse-cholesterol transport (mRCT) in vivo. Because LXR are expressed in multiple tissues involved in RCT (macrophages, liver, intestine), we analyzed the effect of tissue-specific LXR agonism on mRCT.
Methods and Results— In initial studies...